CIK 0001472091
- Non-accelerated filer
- Smaller reporting company
PDS Biotechnology Corp
Sign in to watch- Ticker
- PDSB
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 264231384
- Phone
- +1 800-208-3343
- Business address
- 303A COLLEGE ROAD EAST, PRINCETON, NJ, 08540
- Former names
- Edge Therapeutics, Inc.
- 4 Derivatives Options or other derivatives
- 4 Open-market sale President and CEO sold 5,000 shares at an average $14.95 ($74,725)
- 4 Open-market sale President and CEO sold 5,000 shares at an average $15.42 ($77,100)
- 4 Open-market sale Chief Scientific Officer sold 12,500 shares at an average $13.93 ($174,075)
- 4 Open-market sale President and CEO sold 5,000 shares at an average $13.05 ($65,250)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale President and CEO sold 5,000 shares at $10.11 ($50,550)
- 4 Open-market sale President and CEO sold 7,500 shares at an average $9.86 ($73,925)
- 4 Open-market sale Chief Accounting & Adm Officer sold 3,361 shares at $10.00 ($33,610)
- 4 Derivatives Options or other derivatives
- 4 Open-market sale President and CEO sold 7,500 shares at an average $10.91 ($81,800)
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale President and CEO sold 7,500 shares at an average $10.96 ($82,200)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale President and CEO sold 7,500 shares at an average $10.21 ($76,550)
- 4 Open-market sale Chief Accounting & Adm Officer sold 2,500 shares at $10.42 ($26,050)
- 4 Open-market sale Chief Accounting & Adm Officer sold 1,000 shares at $10.39 ($10,390)
- 4 Open-market sale President and CEO sold 7,500 shares at an average $10.53 ($78,950)
Page 10 of 14 · 278 filings